Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Lenalidomide is an immunomodulatory drug (IMiD) used primarily in oncology. It acts by modulating the immune system and inhibiting tumor angiogenesis. <strong>Molecular Formula</strong>: C13H13N3O3; <strong>CAS No.</strong>: 191732-72-6.</p>
<h3>Application</h3>
<ul>
<li><strong>Hematologic Malignancies:</strong> Treatment of multiple myeloma and myelodysplastic syndromes with del(5q).</li>
<li><strong>Oncology Clinical Trials:</strong> Investigated for solid tumors and combination therapies.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> API production for generic and branded formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in pregnancy due to severe teratogenicity. Requires controlled storage at 20-25°C protected from light. Handling demands PPE to prevent occupational exposure.</p>